| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Vascular Biology,* The Hope Heart Institute, and the Departments of Medicine, Biochemistry, and Bioengineering,¶ University of Washington, Seattle, Washington; and the Department of Surgery, Helsinki University Central Hospital, Helsinki, Finland
SPARC (secreted protein, acidic and rich in cysteine), a matricellular glycoprotein, modulates the interaction of cells with the extracellular matrix (ECM). Recently, accelerated cutaneous wound closure and altered deposition of collagen were reported in SPARC-null mice. Herein we asked whether SPARC might influence the foreign body reaction to biomaterial implants. Polydimethylsiloxane (silicone rubber) disks and cellulose Millipore filters were implanted into wild-type and SPARC-null mice. In wild-type animals, significant levels of SPARC were observed in the cells and the ECM comprising the capsules around the implants. After 4 weeks, SPARC-null mice exhibited a significant decrease in the thickness of the foreign body capsule, as compared to that observed in wild-type mice. A significant reduction in capsular vascular density was also associated with the silicone implants in the SPARC-null animals. Electron microscopy revealed that collagen fibers in the capsules produced by SPARC-null mice were smaller and more uniform in size than those in wild-type animals. Furthermore, staining with picrosirius-red showed that the collagen fibers were less mature in SPARC-null than in wild-type mice. The altered ECM resulting in decreased capsular thickness, indicative of an altered foreign body reaction in SPARC-null mice, implicates SPARC as an important modulator of the encapsulation of implanted biomaterials.
This article has been cited by other articles:
 |
|
 |
|
  A. D. Bradshaw, C. F. Baicu, T. J. Rentz, A. O. Van Laer, J. Boggs, J. M. Lacy, and M. R. Zile Pressure Overload-Induced Alterations in Fibrillar Collagen Content and Myocardial Diastolic Function: Role of Secreted Protein Acidic and Rich in Cysteine (SPARC) in Post-Synthetic Procollagen Processing Circulation, January 20, 2009; 119(2): 269 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W.M. Schellings, D. Vanhoutte, M. Swinnen, J. P. Cleutjens, J. Debets, R. E.W. van Leeuwen, J. d'Hooge, F. Van de Werf, P. Carmeliet, Y. M. Pinto, et al. Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction J. Exp. Med., January 16, 2009; 206(1): 113 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kzhyshkowska, A. Gratchev, C. Schmuttermaier, H. Brundiers, L. Krusell, S. Mamidi, J. Zhang, G. Workman, E. H. Sage, C. Anderle, et al. Alternatively Activated Macrophages Regulate Extracellular Levels of the Hormone Placental Lactogen via Receptor-Mediated Uptake and Transcytosis J. Immunol., March 1, 2008; 180(5): 3028 - 3037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Leslie Environmental movement. Sci. Aging Knowl. Environ., March 15, 2006; 2006(7): nf9 - nf9. [Abstract] [Full Text]
|
|
|
|
 |
|
 N. Said and K. Motamed Absence of Host-Secreted Protein Acidic and Rich in Cysteine (SPARC) Augments Peritoneal Ovarian Carcinomatosis Am. J. Pathol., December 1, 2005; 167(6): 1739 - 1752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. H. Barker, G. Baneyx, M. Cardo-Vila, G. A. Workman, M. Weaver, P. M. Menon, S. Dedhar, S. A. Rempel, W. Arap, R. Pasqualini, et al. SPARC Regulates Extracellular Matrix Organization through Its Modulation of Integrin-linked Kinase Activity J. Biol. Chem., October 28, 2005; 280(43): 36483 - 36493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. E. Gruber, E. H. Sage, H. J. Norton, S. Funk, J. Ingram, and E. N. Hanley Jr. Targeted Deletion of the SPARC Gene Accelerates Disc Degeneration in the Aging Mouse J. Histochem. Cytochem., September 1, 2005; 53(9): 1131 - 1138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sangaletti, L. Gioiosa, C. Guiducci, G. Rotta, M. Rescigno, A. Stoppacciaro, C. Chiodoni, and M. P. Colombo Accelerated dendritic-cell migration and T-cell priming in SPARC-deficient mice J. Cell Sci., August 15, 2005; 118(16): 3685 - 3694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Puolakkainen, A. D. Bradshaw, R. A. Brekken, M. J. Reed, T. Kyriakides, S. E. Funk, M. D. Gooden, R. B. Vernon, T. N. Wight, P. Bornstein, et al. SPARC-thrombospondin-2-double-null Mice Exhibit Enhanced Cutaneous Wound Healing and Increased Fibrovascular Invasion of Subcutaneous Polyvinyl Alcohol Sponges J. Histochem. Cytochem., May 1, 2005; 53(5): 571 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. Barker, P. Framson, P. A. Puolakkainen, M. Reed, S. E. Funk, and E. H. Sage Matricellular Homologs in the Foreign Body Response: Hevin Suppresses Inflammation, but Hevin and SPARC Together Diminish Angiogenesis Am. J. Pathol., March 1, 2005; 166(3): 923 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Lindner, Q. Wang, B. A. Conley, R. E. Friesel, and C. P.H. Vary Vascular Injury Induces Expression of Periostin: Implications for Vascular Cell Differentiation and Migration Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 77 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Sweetwyne, R. A. Brekken, G. Workman, A. D. Bradshaw, J. Carbon, A. W. Siadak, C. Murri, and E. H. Sage Functional Analysis of the Matricellular Protein SPARC with Novel Monoclonal Antibodies J. Histochem. Cytochem., June 1, 2004; 52(6): 723 - 733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Puolakkainen, R. A. Brekken, S. Muneer, and E. H. Sage Enhanced Growth of Pancreatic Tumors in SPARC-Null Mice Is Associated With Decreased Deposition of Extracellular Matrix and Reduced Tumor Cell Apoptosis Mol. Cancer Res., April 1, 2004; 2(4): 215 - 224. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
